Ajax Harwood Clinic

Lupus testing: should I be tested?

Last reviewed 2026-09-23Content vb210b3d7c919
Reference tool — not medical advice. Clinician judgement always required.

Lupus (systemic lupus erythematosus) and what a positive ANA means

Defined testing criteria

Also called: lupus, SLE, systemic lupus erythematosus, positive ANA, autoimmune disease, antinuclear antibody

Patients ask about lupus after reading that fatigue, joint pain, or hair loss can be autoimmune, after a relative is diagnosed, or after an ND or another clinician orders an ANA as part of a broad 'autoimmune panel' and it comes back positive. A positive ANA is common in healthy people and often triggers worry that is out of proportion to what the result means on its own.

Raises suspicion

  • • Inflammatory joint pain or swelling, especially in the small joints of the hands
  • • A malar (butterfly) rash across the cheeks and nose, or a rash that worsens in the sun (photosensitivity)
  • • Unexplained pleuritic chest pain (worse with breathing) or pericardial chest pain
  • • Unexplained low blood counts (anemia, low white cells, or low platelets)
  • • Unexplained kidney problems: foamy urine, swelling in the legs, or high blood pressure with no other cause
  • • Mouth ulcers, unusual hair loss, or Raynaud's phenomenon (fingers turning white or blue in the cold) alongside other features above

Does not raise suspicion

  • • Fatigue, brain fog, or generalized aches alone, with no joint swelling, rash, or organ involvement
  • • A positive ANA found on a general wellness or 'autoimmune' panel, with none of the features above: a positive ANA is common in the general population and does not by itself mean lupus

Red flags

  • • Signs of kidney involvement: foamy urine, significant leg swelling, or new high blood pressure
  • • Chest pain with breathing, or shortness of breath, suggesting pleuritis or pericarditis
  • • New, unexplained bruising, bleeding, or signs of very low blood counts
  • • New seizures, confusion, or other neurologic symptoms in someone with known or suspected lupus

Who to test

  • Inflammatory arthritis, malar or photosensitive rash, unexplained pleuritic or pericardial symptoms, unexplained cytopenias, or unexplained renal disease: Antinuclear antibody (ANA) (Situation-specific), Complete blood count (CBC) (Situation-specific), Kidney function (creatinine/eGFR, BUN, urine albumin-to-creatinine ratio) (Situation-specific)ANA is the correct first test when specific features are present; CBC and kidney function help assess organ involvement. A positive ANA with ongoing suspicion is followed by specific sub-serologies (anti-dsDNA, ENA panel) and rheumatology referral.
  • An inflammatory joint pattern where either lupus or rheumatoid arthritis is a real consideration: Antinuclear antibody (ANA) (Situation-specific), Rheumatoid factor (RF) (Situation-specific)Ordered alongside a joint exam; see the ra tool for the rheumatoid arthritis picture specifically.

More likely instead

  • • Fatigue or generalized aches with a positive ANA and no other feature are far more often explained by fibromyalgia, depression, chronic-fatigue-syndrome, or another cause of fatigue than by lupus
  • • Joint pain without swelling or other systemic features is more often osteoarthritis or a mechanical cause than an autoimmune disease
  • • ra, when the pattern is symmetric small-joint swelling without the rash, serositis, or renal features that point toward lupus

Counselling script

“A positive ANA on its own is common, and about 1 in 7 healthy people have one, so it's not something I'd act on without other features like joint swelling, a specific rash, chest pain when breathing, or a kidney problem. If you have one of those alongside the positive ANA, that's when more specific testing and a rheumatology referral make sense. Without those features, I'd rather look directly at what's causing your tiredness or pain.”

Chart snippet (OSCAR-safe plain text)

Concern discussed, not tested

Concern re: lupus discussed, raised after a positive ANA or patient concern about autoimmune disease.
Discriminating features: inflammatory arthritis, malar or photosensitive rash, pleuritic or pericardial chest pain, unexplained cytopenias, renal disease; absent.
Assessment: isolated positive ANA or nonspecific symptoms, low pre-test probability for SLE.
Plan: ANA not ordered as a screen; reassurance given regarding baseline ANA prevalence.
Ref: Choosing Wisely Canada Rheumatology 2024; Satoh et al. ANA prevalence study 2012.
Patient given info page: https://lupus.ajaxharwoodclinic.com/patient
Revisit if: joint swelling, a new rash, pleuritic chest pain, unexplained low blood counts, or signs of kidney involvement develop.

Testing ordered

Ordered: ANA, with CBC and kidney function to assess organ involvement. Indication: inflammatory arthritis, characteristic rash, serositis, unexplained cytopenias, or unexplained renal disease present.
Plan: if ANA positive with ongoing clinical suspicion, follow with anti-dsDNA/ENA sub-serologies and rheumatology referral.
Ref: Choosing Wisely Canada Rheumatology 2024; Aringer et al. 2019 EULAR/ACR SLE classification criteria.

Revisit if

  • • New joint swelling, rash, or photosensitivity
  • • Pleuritic or pericardial chest pain
  • • Foamy urine, significant leg swelling, or new hypertension
  • • Unexplained bruising, bleeding, or fatigue significant enough to suggest low blood counts

References

  1. 1. Canadian Rheumatology Association / Choosing Wisely Canada. Rheumatology: Eleven Tests and Treatments to Question (2024)ANA should not be ordered as a screening test in patients without specific signs or symptoms of SLE
  2. 2. NIEHS / University of Florida (NHANES analysis). Prevalence and sociodemographic correlates of antinuclear antibodies in the United States (2012)ANA prevalence in the general US population aged 12 and older was 13.8%, establishing a substantial baseline positivity rate unrelated to lupus
  3. 3. EULAR/ACR. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (2019)The 2019 EULAR/ACR SLE classification criteria require a positive ANA at least once as an obligatory entry criterion, followed by weighted clinical and immunologic domain criteria
Evidence notes

Tag A: lupus has defined classification criteria (2019 EULAR/ACR) built on a positive ANA entry criterion plus weighted clinical/immunologic domains, and Choosing Wisely Canada gives a clear negative recommendation for ANA as an undifferentiated screen; not borderline. The 2019 EULAR/ACR criteria are explicitly a research classification tool rather than diagnostic criteria (per Aringer et al.'s own framing), which this record does not spell out in patient-facing text to avoid confusing patients, but the reviewer should confirm that using it here as the 'defined testing criteria' basis for an A tag is acceptable, since clinical diagnosis of lupus in an individual patient still rests on physician judgement rather than meeting the point threshold. Renal, hematologic and serositis red flags are drawn from standard SLE teaching consistent with the domains in [3] rather than a separate verbatim quote naming each one individually. Reviewer: the 2019 EULAR/ACR criteria are classification criteria (for research), not diagnostic criteria. The A tag rests on ANA as a defined entry criterion plus specialist diagnosis. Acceptable, but noted.

General clinical reference for Ajax Harwood Clinic. Not medical advice, and not a substitute for individualized clinical assessment.